KIRKBI, a private holding and investment company, led a $100m Series B funding round in Kerecis, a manufacturer of fish skin-based therapeutic products, with participation from Emerson Collective, BRU and LSV. "Kerecis is a highly innovative company that has built a successful business transforming waste material into unique medical products. We are particularly inspired by the company's approach to sustainability, as we are responsible investors and owners. We are excited to support the company’s continued growth and strategic objectives to improve patient outcomes," Niklas Sjöblom, KIRKBI Senior Director, Long-Term Equity.